Dermapharm Holding SEFRA:DMP 87 FCF Margin % is 15.69% as of Mar. 2026, which is 6% above its 10-year median of 14.75. GuruFocus rates FRA:DMP with a GF Score™ of 87/100 and a GF Value™ of €39.11 (Modestly Overvalued). The stock has 9 warning signs investors should review. Among 958 Drug Manufacturers companies, Dermapharm Holding SE ranks better than 89.46% on this metric.
The historical rank and industry rank for Dermapharm Holding SE's FCF Margin % or its related term are showing as below:
FRA:DMP'
s FCF Margin % Range Over the Past 10 Years
Min: 2.57 Med: 14.75 Max: 24.35
Current: 20.61
During the past 13 years, the highest FCF Margin % of Dermapharm Holding SE was 24.35%. The lowest was 2.57%. And the median was 14.75%.
FRA:DMP's FCF Margin % is ranked better than 89.46% of 958
companies
in the Drug Manufacturers industry
Industry Median: 2.445
vs FRA:DMP: 20.61
Dermapharm Holding SE FCF Margin % Related Terms
Dermapharm Holding SE FCF Margin % Historical Data
* Premium members only.
The historical data trend for Dermapharm Holding SE's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:DMP vs ZTS, UTHR, VTRS: FCF Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Dermapharm Holding SE's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dermapharm Holding SE FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Dermapharm Holding SE's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Dermapharm Holding SE's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dermapharm Holding SE (FRA:DMP) has a FCF Margin % of 15.69% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Dermapharm Holding SE and its competitors. This is near median its historical median of 14.75. Over the past decade, Dermapharm Holding SE's FCF Margin % has ranged from 2.57 to 24.35. According to the industry distribution chart, Dermapharm Holding SE ranks #101 out of 958 companies in the Drug Manufacturers industry, placing it in the top 10.5%.
Is Dermapharm Holding SE's FCF Margin % too high?
Dermapharm Holding SE's current FCF Margin % of 15.69% is near median its 10-year median of 14.75. Over the past 10 years, this metric has ranged from a low of 2.57 to a high of 24.35. The Drug Manufacturers industry median FCF Margin % is 2.45. Dermapharm Holding SE's value of 15.69% is 541.7% above this industry median. Based on the distribution chart, Dermapharm Holding SE ranks #101 out of 958 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Dermapharm Holding SE has a GF Score™ of 87/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Dermapharm Holding SE's FCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Dermapharm Holding SE ranks #101 out of 958 companies for FCF Margin %. This places Dermapharm Holding SE in the top 11% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 2.45. Dermapharm Holding SE's value of 15.69% is 541.7% above this benchmark. Historically, Dermapharm Holding SE's own FCF Margin % has ranged from 2.57 to 24.35 over the past decade. While the company's 10-year median is 14.75 vs. the industry median of 2.45, Dermapharm Holding SE has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.45, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dermapharm Holding SE's current FCF Margin % of 15.69% is 541.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Dermapharm Holding SE and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dermapharm Holding SE's current FCF Margin % is 15.69%, which is near median its own 10-year median of 14.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dermapharm Holding SE stock overvalued right now?
Based on GuruFocus' analysis, Dermapharm Holding SE (FRA:DMP) is currently considered Modestly Overvalued. The stock's GF Value™ is €39.11, compared to a current price of €46.25 — trading 18.3% above its estimated fair value. The current FCF Margin % is 15.69%, which is near median its 10-year median of 14.75 and 541.7% above the Drug Manufacturers industry median of 2.45. Dermapharm Holding SE's overall GF Score™ is 87/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Dermapharm Holding SE (FRA:DMP), the current FCF Margin % is 15.69% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dermapharm Holding SE (FRA:DMP) Overvalued in 2026?
Based on GuruFocus' analysis, Dermapharm Holding SE stock appears to be overvalued.
The current stock price of €46.25 is trading 18.3% above its estimated GF Value™ of €39.11.
GuruFocus considers Dermapharm Holding SE to be Modestly Overvalued.
Key valuation signals for FRA:DMP:
FCF Margin %: 15.69% (near median its 10-year median of 14.75)
GF Value™: €39.11 vs. price of €46.25 (18.3% above fair value)
Industry Position: 541.7% above the Drug Manufacturers median (#101 of 958)
No single metric tells the full story. See the FRA:DMP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dermapharm Holding SE manufactures patent-free branded pharmaceuticals for selected therapy fields, over-the-counter drugs, and natural remedies. The portfolio of the company includes cosmetics, nutritional supplements, and diet and medical devices. Business operating segments include Branded pharmaceuticals, which drive key revenue, Other healthcare products, and Parallel import business. The Branded pharmaceuticals segment covers numerous product areas through a wide variety of items sold under reputable brand names.
87GF Score
Get the complete analysis for FRA:DMP
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:DMP has been successfully added to your 
